40.42Open40.42Pre Close0 Volume0 Open Interest1000.00Strike Price0.00Turnover3337.33%IV-0.72%PremiumAug 23, 2024Expiry Date47.26Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9380Delta0.0041Gamma19.96Leverage Ratio-5436.4235Theta0.0000Rho-18.72Eff Leverage0.0011Vega
Eli Lilly and Co Stock Discussion
$Tesla (TSLA.US)$ closed lowest point of the week yesterday. One of the biggest drops among my portfolio. I am waiting for more positive news from Robotaxi announcement scheduled on Oct 10
I am also holding on to $NVIDIA (NVDA.US)$ as the earnings approaching next week, holding my view th...
Notably, several stocks within these sectors have shown exceptional performance. Pharmaceutical giants with market values in the hundreds of billions, such as $Eli Lilly and Co (LLY.US)$, $Thermo Fisher Scientific (TMO.US)$, $AbbVie (ABBV.US)$, and ...
$Apple (AAPL.US)$ $Microsoft (MSFT.US)$ $NVIDIA (NVDA.US)$ $Alphabet-C (GOOG.US)$ $Amazon (AMZN.US)$ $Meta Platforms (META.US)$ $Eli Lilly and Co (LLY.US)$ $Broadcom (AVGO.US)$ $Tesla (TSLA.US)$ $Exxon Mobil (XOM.US)$ $General Electric (GE.WI.US)$ $CHINA MOBILE (00941.HK)$ $GAZPROM NEFT PUBLIC JOINT STOCK CO LEVEL 1 ADR REPR 5 ORD RUB (GZPFY.US)$ $BP PLC (BP.US)$ $AT&T (T.US)$ $China Construction Bank Corporation (601939.SH)$
$Alphabet-A (GOOGL.US)$ down pre market deapite the good new on its autonomous Robotaxi Waymo. A lot of legal investigations and lawsuits are on going , probably that’s why its down.
$Eli Lilly and Co (LLY.US)$ was strong yesterday due to the encouraging reaults from the new diabetes drug. The momentum continues today but at a smaller gain.
$NVIDIA (NVDA.US)$ is up slightly after the drop yesterday. It might trade sideway in anticipation of th...
$Amazon (AMZN.US)$
👉 Key Highlights:
📍 Eli Lilly's weight loss drug reduces Type 2 diabetes risk by 94% in prediabetic adults.
📍 The drug's active ingredient, tirzepatide, is found in Zepbound and Mounjaro.
📍 Patients on the highest dose saw a 22.9% average weight loss after 176 weeks.
📍 The trial involved over 1,000 adults and spanned 176 weeks, followed by a 17-week cessation period.
📍 The drug maintained an 88% lowe...
MACRO
Investors are digesting comments made duri...
No comment yet